AI-powered search
Try Polaris, our new AI-powered search!

Is there any evidence to suggest ixekizumab is more effective in certain psoriasis phenotypes or patient subgroups?

Featuring Tina Bhutani, MD, MAS |

CEO, Synergy Dermatology  
Associate Clinical Professor of Dermatology  
University of California, SF  
San Francisco, CA

| Published October 18, 2024